All posts
10811 total · page 106 of 217
How regulatory clarity in biologics approval can open new growth frontiers in Indian pharma
Regulatory clarity can boost India's biologics sector significantly.
India’s dependence on imported APIs and strategies for boosting local manufacturing
India seeks to reduce reliance on imported APIs through local strategies.
Acquisition trends in Indian pharma and the growing focus on oncology portfolios
Indian pharma shifts focus to oncology through strategic acquisitions.
Policy environment around medical devices and incentives for growth
Navigating policies can fuel medical device innovation and growth.
How Indian pharma companies are building strength in immunotherapy and biologics
Indian pharma companies are innovating in immunotherapy breakthroughs.
Global regulatory pressures and how Indian pharma is adapting quality and compliance standards
Indian pharma is evolving to meet global compliance demands.
The rising role of specialty drugs and biologics in India’s export mix
India's specialty drugs are transforming global healthcare exports.
Pharma exporters seeking rollback of export bans on India-only drugs and its policy implications
Pharma exporters push to lift bans on India-only drug exports.
Pricing pressures versus value growth in therapy segments such as cardiac and diabetes
Balancing pricing pressures with value growth in therapies.
The future of Indian obesity drug pipelines and the global race to develop novel molecules
India's obesity drug pipeline is vital for global health innovation.
The state of clinical trials in India and recent reforms to attract global studies
India's reforms boost clinical trials, attracting global interest.
How exporters are managing supply chain risks amid API import dependence
Exporters tackle supply chain risks in a shifting landscape.
Opportunities in neglected and rare diseases for Indian pharma innovation
Unlocking new potential in rare disease innovation in India.
Impact of price erosion after patent expiry with case studies from recent launches
Price erosion post-patent expiry reshapes market dynamics.
Effect of geopolitical tensions on pharma raw material sourcing strategies
Geopolitical tensions reshape pharma sourcing strategies dramatically.
Policy reforms shaping India as a manufacturing hub for pharma and devices
India's policy reforms are transforming its pharma manufacturing landscape.
Digitization in pharma regulation with e-governance and approval portals
E-governance transforms pharma regulation and approval processes.
Quality standards and the quest for compliance with USFDA and EU GMP norms
Navigating USFDA and EU GMP norms ensures product safety.
The role of pharma in achieving India’s public health and affordability goals
Pharma plays a crucial role in enhancing India’s public health.
How stock market performance is influencing pharma investor confidence
Pharma stocks are swinging as market trends shift investor trust.
Trends in domestic consumption versus exports in Indian pharmaceuticals
India's pharmaceutical sector is evolving, balancing local needs and global demands.
Evolution of pharma R&D funding and collaboration trends in India
India's pharma R&D funding is evolving with new collaborations.
Regulatory oversight of pharma advertising and promotion in India
India tightens regulations on pharma advertising practices.
Talent and skill development challenges in pharma manufacturing
Pharma manufacturing faces urgent talent and skill gaps.
Export incentives and trade policy changes affecting pharma companies
Pharma firms navigate new export incentives and trade shifts.
Venture capital and startup trends in Indian pharma and biotech
Exploring the rise of venture capital in India's pharma sector.
How mergers and acquisitions are reshaping the competitive landscape
Mergers and acquisitions are redefining industry dynamics.
The rising importance of wellness and preventive care in pharma portfolios
Wellness and preventive care are reshaping pharma strategies.
The outlook for biotech and biosimilars in the Indian market
India's biotech and biosimilars market shows promising growth.
Price regulation and updates to Drug Price Control Orders
Exploring the impact of Drug Price Control Orders on healthcare.
Patent law reforms and their implications for generics and innovators
Patent law reforms reshape the landscape for generics and innovators.
Pharma innovation clusters and their potential for scaling research
Pharma clusters boost collaboration, driving research breakthroughs.
Public-private partnerships in pharma manufacturing and development
Collaborative efforts boost innovation in pharma development.
The role of generics versus branded generics in the Indian healthcare system
Generics offer affordability, but branded generics build trust.
Sustainability and environmental compliance in Indian pharma production
Indian pharma is embracing sustainability for a greener future.
Investment in local API parks and their expected outcomes
Local API parks promise economic growth and community benefits.
Telemedicine and pharmaceutical delivery regulation post COVID
Post-COVID, telemedicine regulations are rapidly evolving.
AI and machine learning applications in Indian drug discovery
AI is transforming drug discovery in India, boosting innovation.
Counterfeit and substandard drugs and policy efforts to address them
Combatting counterfeit drugs requires urgent global policy reform.
How India is preparing for future pandemics with vaccine capacity
India boosts vaccine production to combat future pandemics.
Ethical sourcing and supply chain transparency in pharma ingredients
Ensuring transparency in pharma sourcing builds trust and safety.
How Indian pharma is leveraging global partnerships and licensing deals
Indian pharma thrives through global partnerships and licensing.
Pharma responses to inflation, input cost pressures and currency volatility
Pharma adapts strategies to tackle rising costs and volatility.
The role of biosafety and biosecurity regulations in drug manufacturing
Biosafety regulations ensure safer drug production practices.
Quality failures and recalls in Indian pharma and lessons learned
Indian pharma faces critical quality issues and recalls.
Export destination diversification and reducing reliance on few major markets
Exploring new markets can boost export stability and growth.
Strategies for managing excipient and packaging cost increases
Navigate rising excipient and packaging costs with smart strategies.
Efforts around generating local clinical data in India
Building local clinical data is vital for India's healthcare future.
Trends in vaccine development and local manufacturing capacity
Local vaccine production is reshaping global health strategies.
Patient safety and pharmacovigilance developments in the Indian market
India enhances patient safety through innovative pharmacovigilance.